Pfizer Canada has announced the availability of Xalkori (crizotinib) for patients with anaplastic lymphoma kinase (ALK)-positive advanced or metastatic non-small cell lung cancer (NSCLC) in Canada. A validated ALK assay should be used to ...
Tags: ALK, ALK-positive lung cancer, Pfizer Canada
Pfizer has announced the completion of its purchase of a specialty pharmaceutical company NextWave Pharmaceuticals. Through the acquisition,Pfizer has gained exclusive North American commercialization rights to the FDA approved Quillivant ...
Tags: Pfizer, specialty pharmaceutical company, NextWave Pharmaceuticals
Pfizer, a research-based pharmaceutical company, and Zhejiang Hisun Pharmaceuticals, a Chinese pharmaceutical company, have launched a joint venture, Hisun-Pfizer Pharmaceuticals. Hisun-Pfizer is expected to develop, manufacture and ...
Teva UK has launched generic Tolterodine 1mg and 2mg film-coated tablets, and Tolterodine XL (Mariosea XL) 4mg capsules. Tolterodine is a generic version of Detrusitol (tolterodine) while Tolterodine XL (Mariosea XL) is a generic version ...
Tags: generic tolterodine, medicines, overactive bladder syndrome
Dr. Reddy's Laboratories, an integrated global pharmaceutical company, has introduced Atorvastatin Calcium tablets 10mg, 20mg, 40mg and 80mg in the US. The Atorvastatin Calcium tablets, approved by the United States Food & Drug ...
Tags: anti-cholesterol drug, Atorvastatin Calcium tablets, Lipitor tablets
Mylan and its subsidiary, Mylan Pharmaceuticals, have signed a settlement agreement with Pfizer, Pharmacia & Upjohn Company and Pfizer Health related to Detrol LA patent litigation. The litigation is related to Mylan Pharmaceuticals' ...
Mylan Specialty, a subsidiary of Mylan, and Pfizer have signed a licensing contract for EpiPen Injection 0.3/0.15mg in Japan. Under the license agreement, Pfizer will have the exclusive rights to market and sell EpiPen Injection ...
Tags: Epipen Injection, epinephrine auto-injector, public health
The SFJ Pharmaceuticals Group (SFJ) has partnered with Pfizer to co-develop Dacomitinib as first-line treatment for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of epidermal ...
Tags: Cancer Drug, cell lung cancer, therapy
Mylan has unveiled Atorvastatin calcium tablets of strengths 10mg, 20mg, 40mg and 80mg in Belgium, France, the UK, Ireland and the Netherlands. The generic version of Pfizer's Lipitor is indicated to prevent cardiovascular disease and ...
Tags: Mylan, Atorvastatin calcium tablets, cardiovascular disease
Pfizer and Protalix BioTherapeutics have announced FDA approval of Elelyso (taliglucerase alfa) for injection to treat type 1 Gaucher disease. Elelyso, derived from ProCellEx, is an enzyme replacement therapy (ERT) for the long-term ...
Tags: Protalix/Pfizer Gaucher Drug, Pfizer and Protalix BioTherapeutics
The European Commission has cleared an oral anticoagulant, Eliquis, developed by Bristol-Myers Squibb (BMS) and Pfizer. Eliquis 5mg, trade name of apixaban in Europe, is indicated as a twice-daily drug for preventing strokes and systemic ...
Tags: BMS-Pfizer Oral Anticoagulant, oral anticoagulant, Eliquis, apixaban
The Australian Competition and Consumer Commission will not oppose the proposed acquisition of Pfizer Nutrition,a global infant nutrition business,from Pfizer Inc by NestléS.A,after accepting a court-enforceable undertaking.See ...
Teva Pharmaceutical Industries has decided not to launch atorvastatin, a generic version of Pfizer's Lipitor. The decision will help Ranbaxy Laboratories and Dr Reddy's Laboratories gain larger sales of the medicine in the US, the ...
Pfizer has granted exclusive development and marketing rights to ChemRar group company SatRx for their DPP(1)-IVi compound, PF-00734200 for type 2 diabetes (T2D). T2D is one of the most burdensome chronic non-communicable diseases, which ...
Tags: Satrx Exclusive License, epidemic proportions, R&D portfolio
US-based Pfizer has reached five-year public goal of reducing its greenhouse gas emissions (GHG) by 20% in a year earlier than expected. As a result of the achievement within four years, Pfizer achieved $85m in annualized project savings. ...
Tags: gas emissions, environmental sustainability, energy conservation